Navigation Links
Marshall Edwards Receives $4 Million Subscription From Novogen In Rights Offering
Date:5/8/2012

ities laws of any such state or jurisdiction. A copy of the prospectus for the rights offering may be obtained by contacting the Company's investor relations department at investor@marshalledwardsinc.com or (858) 369-7199.

About Marshall Edwards

Marshall Edwards, Inc. (Nasdaq: MSHL) is a San Diego-based oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism. The Company's lead drug candidates, ME-143 and ME-344, have been shown in laboratory studies to interact with specific enzyme targets resulting in inhibition of tumor cell metabolism, a function critical for cancer cell survival. Marshall Edwards initiated a Phase I clinical trial of intravenous ME-143 in patients with solid refractory tumors in September 2011 and plans to present safety and pharmacokinetic data from the trial at the American Society of Clinical Oncology Annual Meeting in June 2012. The Company received approval of its Investigational New Drug application for ME-344 in April 2012 and initiated a Phase I clinical trial of intravenous ME-344 in patients with solid refractory tumors shortly thereafter. For more information, please visit www.marshalledwardsinc.com.

Under U.S. law, a new drug cannot be marketed until it has been investigated in clinical trials and approved by the FDA as being safe and effective for the intended use. Statements included in this press release that are not historical in nature are "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. You should be aware that our actual results could differ materially from those contained in the forward-looking statements, which are based on management's current expectations and are subject to a num
'/>"/>

SOURCE Marshall Edwards, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Marshall Edwards Submits Investigational New Drug Application for Oncology Drug Candidate ME-344
2. Marshall Edwards CEO to Present at Roth Capital Partners Growth Stock Conference
3. Marshall Edwards Announces Rights Offering to Stockholders
4. Marshall Edwards Adds $2 Million in Private Placement
5. Marshall Edwards Announces $2 Million Private Placement
6. Marshall Edwards Announces First Patient Dosed in Phase I Clinical Trial of Lead Oncology Drug Candidate ME-143
7. Marshall Edwards Announces Initiation of Phase I Clinical Trial of Lead Oncology Drug Candidate ME-143
8. Marshall Edwards Announces FDA Approval of Investigational New Drug Application for Lead Candidate ME-143
9. Marshall Edwards Announces Publication of Pre-Clinical Study Showing Activity in Chemotherapy-Resistant Ovarian Cancer Stem Cells
10. Marshall Edwards Announces Publication of Pre-Clinical Studies in Pancreatic Cancer
11. Marshall Edwards Announces Closing of Asset Purchase Agreement With Novogen
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014  According to Millennium ... technology market intelligence, the United States ... (TEO) device markets will expand moderately through 2022, ... segments. In particular, increasing interest in drug-eluting beads ...
(Date:1/15/2014)... YORK , Jan. 15, 2014 ... report is available in its catalogue: ... India Drug Forecast and Market Analysis to ... PharmaPoint: Atopic Dermatitis - India Drug ...
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com ... is available in its catalogue: ... Advanced Drug Delivery Systems -- Focus on ... STUDY OBJECTIVES A ...
Breaking Medicine Technology:US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18
... 2011 Reportlinker.com announces that a new market ... A Global Overview of Herbal/Traditional Products ... The quest for "safer and natural" options ... recognising the benefits of traditional medicine, consumers are ...
... March 14, 2011 Reportlinker.com announces that a ... catalogue: Hepatitis A Preventive Vaccines ... http://www.reportlinker.com/p0453473/Hepatitis-A-Preventive-Vaccines---Pipeline-Assessment-and-Market-Forecasts-to-2017.html ... Market Forecasts to 2017 SummaryGlobalData, ...
Cached Medicine Technology:Reportlinker Adds A Global Overview of Herbal/Traditional Products 2Reportlinker Adds Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to 2017 2Reportlinker Adds Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to 2017 3
(Date:7/11/2014)... hot Texas sun won’t keep kids from having fun outdoors ... had previously invested in a playground structure to augment their ... for an innovative solution to help protect children from excessive ... Rectangular Shade from APCPLAY as the perfect solution to providing ... shade measures 24’W x 34’H x 11’H to fully encompass ...
(Date:7/11/2014)... ASHBURN PSYCHOLOGICAL AND PSYCHIATRIC SERVICES , On July ... an intellectual disability or autism to have a special code ... to alert law enforcement or first responders that they are ... inspired by a central Virginia mother, Ms. Pam Mines, who ... autistic son, JP. During a news conference after the ...
(Date:7/10/2014)... acids had healthier joints than those fed diets high ... to Duke Medicine researchers. , The findings, published in ... on July 11, 2014, suggest that unhealthy dietary fats ... osteoarthritis. , "Our results suggest that dietary factors play ... link between obesity and osteoarthritis," said Farshid Guilak, Ph.D., ...
(Date:7/10/2014)... Thousands of researchers from more than ... 13-17 to reveal the latest study results, theories ... in dementia science. The Alzheimer’s Association International Conference ... kind. , As part of the Alzheimer’s Association’s ... generating new knowledge about dementia and fostering a ...
(Date:7/10/2014)... (PRWEB) July 10, 2014 CBPartners, a ... industry, has launched a new website. The redesigned ... as increased access to the firm’s thought pieces, blog ... an ideal platform to showcase our insights, capabilities, and ... says CBPartners’ Chief Executive Officer, Cyrus Chowdhury. “An ...
Breaking Medicine News(10 mins):Health News:Cool Fun Under the Texas Sun: Godley Elementary School Purchases Shade Structure from APCPLAY© 2Health News:Recent Special “Autism” Code on Virginia Driver’s Licenses and ID Cards Goes into Law: Helpful or Discriminatory for Individuals on the Autistic Spectrum? 2Health News:Recent Special “Autism” Code on Virginia Driver’s Licenses and ID Cards Goes into Law: Helpful or Discriminatory for Individuals on the Autistic Spectrum? 3Health News:Omega 3 fatty acids lessen severity of osteoarthritis in mice 2Health News:CBPartners Announces New Website 2
... a new method to reform the mandible (lower jaw) of ... the study, Eric Moore, M.D., said that without reconstructive procedures ... be seen in mandible-removed oral cancer patients. ,‘We ... patients and a good tool for reconstructive surgeons,’ says Daniel ...
... foods targeted at improving women's health researchers are facing ... upon women's participation in food trials and studies. ... addressed this lack of available women's research at this ... EXPO?, the world's largest annual meeting on food science, ...
... Energy's Pacific Northwest National Laboratory and UCLA's David Geffen ... diseases// is linked to a natural by-product of oxidation ... Gehrig's disease and other brain disorders are a few ... that can be credited to oxidative stress, the cell ...
... the habit, they may gain about 20 pounds, according to ... commonly cited 5 pounds// to 15 pounds. ,The ... activity counseling along with smoking cessation programs, say study authors ... of the University of California, Berkeley. ,The authors ...
... announced on Wednesday that as many as three million ... Southern Africa. //WFP executive director James Morris said that ... a distribution problem. ,"Good harvests do not ... "Food and good nutrition are crucial in battling against ...
... that allows breast cancer cells to evade the body’s natural immune ... a study by Keck School of Medicine of USC scientists published ... the American Journal of Pathology, is the first to identify how ... – functions. ,“The important aspect of this study ...
Cached Medicine News:Health News:Jaw Reconstruction could be Possible in Oral Cancer Patients 2Health News:Jaw Reconstruction could be Possible in Oral Cancer Patients 3Health News:Women Doubtful of Food Research Benefiting Them 2Health News:Scientist Optimistic In Breakthrough For Causes Of Neurodegenerative Diseases 2Health News:Smokers are Prone to Weight Gain After Quitting 2Health News:Researchers Investigate Protein that Protects Tumors 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: